CRANBURY, N.J., March 23, 2020 /PRNewswire/ -- With the emergence of COVID-19 (novel coronavirus) has come tremendous global concern and uncertainty. In response, the Academy of Oncology Nurse & Patient Navigators (

NEW HAVEN, Conn., March 23, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or, the "Company") today announced a successful end of Phase 2 clinical and nonclinical interaction with the U.S. Food and Drug Administration (FDA) for intranasal vazegepant for the acute treatment of migraine. The Company addressed all issues rais

ATLANTA, March 23, 2020 /PRNewswire/ -- Aaron's, Inc. (NYSE: AAN), a leading omnichannel provider of lease-purchase solutions, today announced business updates in connection with the continued spread of COVID-19.

PALO ALTO, Calif., March 23, 2020 /PRNewswire/ -- As people deal with illness and quarantines, new polling from LeanIn.Org shows that three-quarters of Americans (76%) support expanding paid sick leave access beyond the provisions included in the

PLANTATION, FL, March 23, 2020 /PRNewswire/ - Akumin Inc. (TSX: AKU.U, AKU) ("Akumin") announced today it will be dedicating 10 of its freestanding, outpatient diagnostic imaging centers (the "Designated Centers") across its regions to focus specifically on patients who have been diagnosed with an active case of COVID-19, the disease caused by the novel cor

PRINCETON, N.J., March 23, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its ongoing collaboration with the University of Hawaiʻi at Mānoa (UH Māno

ELMWOOD PARK, N.J., March 23, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Detroit to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations for

SUZHOU, China, and ROCKVILLE, Md., March 23, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the global Phase Ib/II clinical study of APG-2575, a Bcl-2 selec

SUZHOU, China, and ROCKVILLE, Md., March 23, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the global Phase Ib/II clinical study of APG-2575, a Bcl-2 selec

SUZHOU, China, and ROCKVILLE, Md., March 23, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the global Phase Ib/II clinical study of APG-2575, a Bcl-2 selec